透明细胞癌-话题@MedSci

#透明细胞癌#

34篇内容 | 1699人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2010063, encodeId=4eeb2010063ee, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=CLIN CANCER RES：ENMD-2076治疗卵巢透明细胞癌, objectType=article, longId=156350, objectId=b0c5156350d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0c5156350d9, replyNumber=0, likeNumber=77, createdTime=2019-09-19, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0c5156350d9, moduleTitle=CLIN CANCER RES：ENMD-2076治疗卵巢透明细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0c5156350d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010060, encodeId=997a20100606a, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=MRI诊断肾盂透明细胞癌一例, objectType=article, longId=133809, objectId=424013380921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=424013380921, replyNumber=0, likeNumber=58, createdTime=2018-11-06, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=424013380921, moduleTitle=MRI诊断肾盂透明细胞癌一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=424013380921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010061, encodeId=27502010061e6, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Int J Oral Max Surg：头颈部涎腺透明细胞癌的临床和组织病理学分析, objectType=article, longId=136171, objectId=b92d1361e199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b92d1361e199, replyNumber=0, likeNumber=100, createdTime=2018-11-10, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b92d1361e199, moduleTitle=Int J Oral Max Surg：头颈部涎腺透明细胞癌的临床和组织病理学分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b92d1361e199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010059, encodeId=12f6201005982, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例, objectType=article, longId=124873, objectId=cba21248e361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba21248e361, replyNumber=0, likeNumber=83, createdTime=2018-05-10, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba21248e361, moduleTitle=依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cba21248e361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010058, encodeId=6de020100580b, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=2017 EAU指南：转移性肾透明细胞癌的一线治疗, objectType=article, longId=123202, objectId=2dd4123202cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dd4123202cf, replyNumber=0, likeNumber=67, createdTime=2018-11-14, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dd4123202cf, moduleTitle=2017 EAU指南：转移性肾透明细胞癌的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dd4123202cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010057, encodeId=055c201005e6f, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Oncotarget：一种肾透明细胞癌的非侵入性生物标志物，miR-210-3p。, objectType=article, longId=117878, objectId=b6b011e87899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6b011e87899, replyNumber=0, likeNumber=64, createdTime=2018-03-26, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6b011e87899, moduleTitle=Oncotarget：一种肾透明细胞癌的非侵入性生物标志物，miR-210-3p。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6b011e87899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010056, encodeId=19ea2010056d3, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Sci Rep：新的研究或为肾透明细胞癌的预后提供更佳的方法, objectType=article, longId=111938, objectId=78f011193844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f011193844, replyNumber=0, likeNumber=55, createdTime=2018-03-24, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f011193844, moduleTitle=Sci Rep：新的研究或为肾透明细胞癌的预后提供更佳的方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78f011193844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010054, encodeId=d4a42010054fd, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=2016EAU指南——血管内皮生长因子受体抵抗的肾脏透明细胞癌的靶向治疗发布, objectType=article, longId=79519, objectId=e5e8e951937, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e8e951937, replyNumber=0, likeNumber=65, createdTime=2017-04-15, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e8e951937, moduleTitle=2016EAU指南——血管内皮生长因子受体抵抗的肾脏透明细胞癌的靶向治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e8e951937)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010055, encodeId=e387201005593, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=JAMA：帕唑替尼与依维莫司交替方案VS帕唑替尼连续方案在治疗转移性肾透明细胞癌患者上无显著性差异, objectType=article, longId=83606, objectId=76088360623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76088360623, replyNumber=0, likeNumber=58, createdTime=2017-05-28, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76088360623, moduleTitle=JAMA：帕唑替尼与依维莫司交替方案VS帕唑替尼连续方案在治疗转移性肾透明细胞癌患者上无显著性差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76088360623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010053, encodeId=42462010053b5, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期), objectType=article, longId=73685, objectId=920ee368569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920ee368569, replyNumber=0, likeNumber=71, createdTime=2016-11-08, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920ee368569, moduleTitle=JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920ee368569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010052, encodeId=2915201005221, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=ESMO 2014：抗PD-L1联合贝伐单抗用于肾透明细胞癌安全和效果良好, objectType=article, longId=40875, objectId=3d03408e567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d03408e567, replyNumber=0, likeNumber=0, createdTime=2015-07-11, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d03408e567, moduleTitle=ESMO 2014：抗PD-L1联合贝伐单抗用于肾透明细胞癌安全和效果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d03408e567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010051, encodeId=e83f201005176, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=ASCO 2014：PC与CPT-P方案一线治疗进展期卵巢透明细胞癌疗效相当, objectType=article, longId=36097, objectId=87e53609e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87e53609e2a, replyNumber=0, likeNumber=93, createdTime=2014-12-16, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87e53609e2a, moduleTitle=ASCO 2014：PC与CPT-P方案一线治疗进展期卵巢透明细胞癌疗效相当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87e53609e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010050, encodeId=2a66201005070, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=JCO:PET/CT可诊断肾透明细胞癌, objectType=article, longId=13660, objectId=81b21366012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81b21366012, replyNumber=0, likeNumber=84, createdTime=2013-01-20, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81b21366012, moduleTitle=JCO:PET/CT可诊断肾透明细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81b21366012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010049, encodeId=76dd201004935, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=Mol Can Thera：联合用药可有效治疗乳腺癌和肾透明细胞癌, objectType=article, longId=8571, objectId=9ef685e183, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ef685e183, replyNumber=0, likeNumber=79, createdTime=2013-07-13, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ef685e183, moduleTitle=Mol Can Thera：联合用药可有效治疗乳腺癌和肾透明细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ef685e183)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010048, encodeId=b09a20100487d, content=<a href='/topic/show?id=6d13948196c' target=_blank style='color:#2F92EE;'>#透明细胞癌#</a>, objectTitle=晚期卵巢透明细胞癌姑息性化疗无明显获益, objectType=article, longId=2963, objectId=3015296366, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3015296366, replyNumber=0, likeNumber=83, createdTime=2011-10-03, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3015296366, moduleTitle=晚期卵巢透明细胞癌姑息性化疗无明显获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3015296366)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

透明细胞癌

2020-05-29

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

CLIN CANCER RES：ENMD-2076治疗卵巢透明细胞癌

2019-09-19

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

MRI诊断肾盂透明细胞癌一例

2018-11-06

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Int J Oral Max Surg：头颈部涎腺透明细胞癌的临床和组织病理学分析

2018-11-10

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例

2018-05-10

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

2017 EAU指南：转移性肾透明细胞癌的一线治疗

2018-11-14

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Oncotarget：一种肾透明细胞癌的非侵入性生物标志物，miR-210-3p。

2018-03-26

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Sci Rep：新的研究或为肾透明细胞癌的预后提供更佳的方法

2018-03-24

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

2016EAU指南——血管内皮生长因子受体抵抗的肾脏透明细胞癌的靶向治疗发布

2017-04-15

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

JAMA：帕唑替尼与依维莫司交替方案VS帕唑替尼连续方案在治疗转移性肾透明细胞癌患者上无显著性差异

2017-05-28

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期)

2016-11-08

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

ESMO 2014：抗PD-L1联合贝伐单抗用于肾透明细胞癌安全和效果良好

2015-07-11

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

ASCO 2014：PC与CPT-P方案一线治疗进展期卵巢透明细胞癌疗效相当

2014-12-16

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

JCO:PET/CT可诊断肾透明细胞癌

2013-01-20

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

Mol Can Thera：联合用药可有效治疗乳腺癌和肾透明细胞癌

2013-07-13

wmr111 (审核中...)

前往app查看评论内容

#透明细胞癌#

晚期卵巢透明细胞癌姑息性化疗无明显获益

2011-10-03

科室
- - 订阅+
  - 更多科室
工具
服务